Report Feature
The future of the genome editing market looks promising with opportunities in cell line engineering, animal genetic engineering, and plant genetic engineering applications. The global genome editing market is expected to grow with a CAGR of 15%-20% from 2020 to 2025. The major drivers for this market are rising government funding and growth in the number of genomics projects and expanding application areas of genomics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genome editing market report, please download the report brochure.
In this market, CRISPR is the largest technology of genome editing, whereas biotechnology & pharmaceutical companies is the largest end use. Growth in various segments of the genome editing market are given below:
The study includes trends and forecast for the global genome editing market by technology, delivery method, application, service, end use, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- CRISPR/Cas9
- TALENs
- ZFN
- Others
By Delivery Method [Value ($ Million) shipment analysis for 2014 – 2025]:
- Ex-Vivo
- In-Vivo
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Other Applications
By Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Contract
- In-House
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the genome editing companies profiled in this report include Thermo Fisher Scientific, Merck, Horizon Discovery, Lonza, GenScript, Eurofins Scientific and Sangamo Therapeutics.
Lucintel forecasts that CRISPR will remain the largest technology segment over the forecast period, as it can be tailored to treat patient-specific mutations for genetic diseases.
Within this market, biotechnology & pharmaceutical companies will remain the largest end use segment over the forecast period due to the large number of research projects carried out in gene engineering for the development of novel therapeutics.
North America will remain the largest region over the forecast period due to higher adoption of advanced techniques in the research institutes based in the US and higher incidence of monogenic diseases in the region.
|
Features of the Global Genome Editing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global genome editing market by technology (CRISPR/CAS9, TALENs, ZFN, and others), delivery method (ex-vivo and in-vivo), application (cell line engineering, animal genetic engineering, plant genetic engineering, and other applications), service (contract and in-house), end use (biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genome editing market? Q.5 What are the business risks and threats to the global genome editing market? Q.6 What are the emerging trends in this genome editing market and the reasons behind them? Q.7 What are some changing demands of customers in this genome editing market? Q.8 What are the new developments in this genome editing market? Which companies are leading these developments? Q.9 Who are the major players in this genome editing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this genome editing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global genome editing market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Technology Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Technology (CRISPR/Cas9, TALENs, ZFN, and Others), Delivery Method (Ex-Vivo and In-Vivo), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications), Service (Contract and In-House), and End Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Genome Editing Market
4.1 Global Genome Editing Market by Region
4.2.1 Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.2.2 Market by Delivery Method: Ex-Vivo and In-Vivo
4.2.3 Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4 Market by Service: Contract and In-House
4.2.5 Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.2.6 The United States Genome Editing Market
4.2.7 The Canadian Genome Editing Market
4.2.8 The Mexican Genome Editing Market
4.3.1 Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.3.2 Market by Delivery Method: Ex-Vivo and In-Vivo
4.3.3 Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4 Market by Service: Contract and In-House
4.2.5 Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.3.6 The United Kingdom Genome Editing Market
4.3.7 The Spanish Genome Editing Market
4.3.8 The German Genome Editing Market
4.3.9 The French Genome Editing Market
4.4.1 Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.4.2 Market by Delivery Method: Ex-Vivo and In-Vivo
4.4.3 Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.4.4 Market by Service: Contract and In-House
4.4.5 Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.4.6 The Chinese Genome Editing Market
4.4.7 The Indian Genome Editing Market
4.4.8 The Japanese Genome Editing Market
4.5.1 Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.5.2 Market by Delivery Method: Ex-Vivo and In-Vivo
4.5.3 Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.5.4 Market by Service: Contract and In-House
4.5.5 Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.5.6 Brazilian Genome Editing Market
7.1.1 Growth Opportunities for the Global Genome Editing Market by Technology
7.1.2 Growth Opportunities for the Global Genome Editing Market by Delivery Method
7.1.3 Growth Opportunities for the Global Genome Editing Market by Application
7.1.4 Growth Opportunities for the Global Genome Editing Market by Service
7.1.5 Growth Opportunities for the Global Genome Editing Market by End Use
7.1.6 Growth Opportunities for the Global Genome Editing Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
